Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ionis Pharmaceuticals Inc (NASDAQ:IONS)

44.59
Delayed Data
As of Feb 24
 +0.24 / +0.54%
Today’s Change
19.59
Today|||52-Week Range
57.00
-6.77%
Year-to-Date
Ionis (IONS) Q4 Earnings: What's in the Cards for the Stock?
Feb 21 / Zacks.com - Paid Partner Content
3 Biotechs With Tremendously Promising Pipelines
Feb 15 / MotleyFool.com - Paid Partner Content
Did Biogen Inc. Shoot Itself in the Foot?
Feb 21 / MotleyFool.com - Paid Partner Content
Ionis Pharmaceuticals (IONS) Sees Hammer Chart Pattern: Time to Buy?
Feb 15 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close44.35
Today’s open43.96
Day’s range43.29 - 45.05
Volume1,178,183
Average volume (3 months)2,170,746
Market cap$5.4B
Dividend yield--
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)-124.24%
Earnings growth (this year)-38.29%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+32.47%
P/E ratioNM
Price/Sales26.13
Price/Book26.73

Competitors

 Today’s
change
Today’s
% change
VRXValeant Pharmaceutic...-0.40-2.41%
MNKMallinckrodt Plc-1.09-2.00%
TAROTaro Pharmaceutical ...-2.36-1.98%
ACADACADIA Pharmaceutica...-0.68-1.72%
Data as of 4:02pm ET, 02/24/2017

Financials

Next reporting dateFebruary 28, 2017
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$283.7M
Annual profit (last year)-$88.3M
Net profit margin-31.12%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Stanley T. Crooke
Chief Operating Officer &
Director
B. Lynne Parshall
Corporate headquarters
Carlsbad, California

Forecasts


Search for Jobs